APR Contests Singapore HSA's Medicube Dye Recall
South Korean beauty firm APR stated its Medicube PDRN Pink Collagen Capsule Cream contains no Sudan Red dye, challenging earlier Singapore Health Sciences Authority (HSA) recall actions.
APR Reports No Banned Dye in Medicube Cream
South Korean beauty company APR stated on Friday that laboratory tests found no Sudan Red dye in its Medicube PDRN Pink Collagen Capsule Cream. This announcement followed Singapore's Health Sciences Authority (HSA) flagging specific product batches for recall.
APR reported that certified institutions, including those in Korea, analyzed samples corresponding to the batch numbers cited by HSA: 2E122I.2E117I and 2E191G.2E193G. The company claims these tests detected no prohibited dye. APR also conducted testing at an HSA-certified institution, at the regulator's request.
The company stated these results align with HSA's own findings of no detection in products officially supplied by APR's Singapore entity. Sudan Red is an industrial azo dye restricted from cosmetic and food use due to suspected genotoxic and carcinogenic properties.
HSA Recall and APR's Authenticity Dispute
HSA initiated a recall on August 26, after discovering trace amounts of Sudan IV in two batches of the Medicube cream. These batches were sold by Venus Beauty Pte. Ltd., identified as one of three distributors under HSA's review. HSA cleared batches from other distributors, including APR's official Singapore distributor, for resale.
APR contested the authenticity of the samples HSA tested. The company stated it had no record of exporting the specific batch numbers in question to Singapore. APR further noted that it has never supplied or exported products to Venus Beauty, which HSA identified as the seller of the tested samples.
An APR official indicated the company is reviewing distribution facts, questioning the genuineness of HSA's samples and their path to the seller.
Implications for Asia's Beauty Supply Chains
This incident highlights supply chain integrity challenges for beauty brands operating in Asia. Companies must verify distribution channels to prevent unauthorized product entry into markets. APR stated it will continue to address false claims with verified facts, while maintaining its focus on quality and transparency.
The company also noted the presence of unauthorized products in some markets, advising that items purchased outside official retailers cannot be verified. For Asian beauty brands, this case underscores the importance of robust traceability systems and clear distributor agreements.
Regulators across Southeast Asia may increase scrutiny on product origins and distribution networks. Brands should strengthen their official sales channels and consumer education on product authenticity.
Three newsletters, one newsroom.
The Beauty Brief delivers Asia's beauty week every Monday. Regulatory Radar tracks the rule changes that move markets. Trend Pulse decodes what consumers want next. All free to start.
